Posted on 3/8/17
Cambrex: An Undervalued Stock
IMAGE SOURCE: CHRIS POTTER/FLICKR.Company OverviewCambrex Corporation (NYSE:CBM) is a specialized pharmaceutical contract manufacturing organization, referred to as a CMO. Cambrex offers 3 primary services: Custom Development . . .
Posted on 3/8/17
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Novartis
Few companies can claim to have helped improve more individuals' eyesight than Regeneron Pharmaceuticals (NASDAQ:REGN) and Novartis (NYSE:NVS). Regeneron's Eylea and Novartis' Lucentis stand out as . . .
Posted on 3/8/17
3 Biotech Stocks You Don't Have to Babysit
The biotechnology industry is typically characterized by companies with huge potential, but little to no revenue. This situation often leads to some gut-wrenching volatility that keeps . . .
Posted on 3/8/17
House Republicans Take an Axe to the Obamacare Mandate
Donald Trump's promise to repeal Obamacare and its individual mandate took steps forward this week when republicans in the House of Representatives unveiled their replacement plan. . . .
Posted on 3/8/17
Fibrocell Announces Convertible Preferred Stock Financing for $8.0 Million
EXTON, Pa., March 07, 2017 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective . . .
Posted on 3/8/17
Quest Diagnostics To Speak At The Barclays Global Healthcare Conference
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Barclays Global Healthcare Conference . . .
Posted on 3/7/17
ExpressCare Opens 30th Urgent Care Facility With Newest Location In Mt. Airy Section Of Carroll County, Maryland
Locally-owned urgent care center, which partners with LifeBridge Health, intends to open approximately ten new locations within next year, with focus on Pennsylvania and DelawareExpressCare, a . . .
Posted on 3/7/17
Why Celldex Therapeutics Stock Gained 10% in February
What happenedAccording to data from S&P Global Market Intelligence, shares of the clinical-stage cancer specialist Celldex Therapeutics (NASDAQ:CLDX) gained 10% last month and did so without . . .
Posted on 3/6/17
Here's Why Pfizer Rallied 7.7% in February
What happenedAccording to data from S&P Global Market Intelligence, shares of Pfizer (NYSE:PFE) gained 7.7% in February. The move has added more than $11 billion to . . .
Posted on 3/6/17
Billionaires Love These 3 Healthcare Stocks
Follow the money. And when there's a lot of money, follow especially closely.Billionaire investors are putting plenty of money into healthcare stocks these days. For the . . .
Posted on 3/3/17
Safeguard Scientifics' (SFE) CEO Steve Zarrilli on Q4 2016 Results - Earnings Call Transcript
Safeguard Scientifics, Inc. (NYSE:SFE)Q4 2016 Earnings Conference CallMarch 02, 2017 09:00 PM ETExecutivesJohn Shave - IRSteve Zarrilli - CEOJeff McGroarty - CFOAnalystsJim Macdonald - First AnalysisLee . . .
Posted on 3/3/17
4 Reasons Johnson & Johnson Surged 8% in February
What happenedShares of healthcare conglomerate Johnson & Johnson (NYSE:JNJ) delivered an incredibly strong performance in February, rising 8% during the month, according to data from S&P . . .
Posted on 3/3/17
Merk: The Keytruda Success Story
Keytruda is the cancer drug you cannot afford to ignore. Keytruda has proved to be complete success story across multiple indications. However, a major part of . . .
Posted on 3/3/17
Why Celgene's Shares Rallied Higher in February
What happenedAfter reporting fourth-quarter financials in late January and announcing positive phase 3 trial results for its promising multiple sclerosis drug in February, shares in Celgene . . .
Posted on 3/3/17
Micro Interventional Device Wins CRT 2017's "Top Cardiovascular Innovation Award"
Micro Interventional Devices, Inc™ (MID), is pleased to announce that it is the recipient of the CRT 2017 "Top Cardiovascular Innovation Award" for the company's MIA™ . . .
Posted on 3/2/17
Integral Molecular and Integrated BioTherapeutics Initiate Collaboration
PHILADELPHIA & ROCKVILLE, Md.--(BUSINESS WIRE)--Integral Molecular and Integrated BioTherapeutics have teamed up in the fight against the global health crises posed by Ebola and Zika viruses, . . .
Posted on 3/2/17
Medical Guardian Chosen as "Best Overall Company" in Medical Alerts Industry by BestCompany.com
Medical Guardian, a leading provider of personal emergency response systems, has been awarded the “Best Overall Company” in the Medical Alerts industry by bestcompany.com, an independent . . .
Posted on 3/2/17
Interleukin Genetics Establishes Partnership with Greater Philadelphia Business Coalition on Health
Expands Availability of the ILUSTRATM Inflammation Management Program with Deployment of First Employer in Philadelphia Region Interleukin Genetics, Inc. (OTCQB: ILIU), a life sciences company focused . . .
Posted on 3/2/17
Better Buy: Johnson & Johnson vs. AbbVie
Dividend Aristocrats. Biopharmaceutical leaders. Great stock picks.All three of these descriptions apply to both Johnson & Johnson (NYSE:JNJ) and AbbVie(NYSE:ABBV). The performance of the two drug . . .
Posted on 3/2/17
Medical Oncology Hematology Consultants Joins The US Oncology Network
NEWARK, Del.--(BUSINESS WIRE)--Medical Oncology Hematology Consultants the premier provider of advanced treatments for cancer and blood disorder patients in Delaware for more than 30 years, has . . .
Posted on 3/1/17
Philadelphia Research Consortium Launched to Speed Access to Preclinical Research Capabilities Across Philadelphia’s Life Sciences Community
The Wistar Institute, together with many regional academic institutions driving life sciences discoveries, has launched the Philadelphia Research Consortium – a preclinical research network for facilitating . . .
Posted on 3/1/17
Pfizer Stock History: How the Drugmaker Became an Industry Giant
For nearly 170 years, Pfizer (NYSE:PFE) has sought to help improve the world. Yet it took nearly a century after its 1849 founding before Pfizer started . . .
Posted on 3/1/17
Better Buy: Celldex Therapeutics, Inc. vs. Juno Therapeutics Inc
Celldex Therapeutics, Inc. (NASDAQ:CLDX) and Juno Therapeutics Inc(NASDAQ:JUNO) are two of last year's worst-performing biotech stocks. Both companies suffered upsetting failures with their leading new drug . . .
Posted on 3/1/17
Blackfynn And CHOP Extend, Expand Partnership On Pediatric Cancer Research
The latest news from realLIST honoree startup Blackfynn is a revamped partnership with the Children’s Hospital of Philadelphia.
Posted on 2/28/17
Alliqua BioMedical Closes $2.8M Private Placement
YARDLEY, Pa., Feb. 28, 2017 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA), a regenerative technologies company committed to restoring tissue and rebuilding lives, today announced that . . .

